Calcineurin Inhibitors: all 995 studies that test it
Page 6 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML PatientsStatus unknownNCT03150134Phase 4
- A Drug-Drug Interaction Study to Evaluate Drug Transporter InteractionsCompletedNCT03136237Phase 1
- Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine CorneaStatus unknownNCT03105466Not applicable
- Drug/Drug Interactions With F901318WithdrawnNCT03095547Phase 1
- Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusCompletedNCT03083782Phase 1
- Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney TransplantationCompletedNCT03076151Phase 4
- Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for VitiligoCompletedNCT03047733Not applicable
- A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityCompletedNCT03032783Phase 2
- Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand EczemaStatus unknownNCT03026946Phase 3
- Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT03013933Phase 1
- AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney TransplantationStatus unknownNCT03005236Phase 4
- Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical StudyCompletedNCT02970630Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive RegimenTerminatedNCT02963103Phase 4
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.Active, not recruitingNCT02936505Not applicable
- De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised StudyWithdrawnNCT02909335Phase 3
- Cyclosporine A Pretreatment and Kidney Graft FunctionCompletedNCT02907554Phase 4
- Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT02896101Phase 3
- Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After ConversionStatus unknownNCT02882113Phase 4
- Postconditioning by Cyclosporin A in Pulmonary TransplantationWithdrawnNCT02876250Phase 3
- Topical Solution for the Treatment of Atopic DermatitisCompletedNCT02865356Phase 2
- Omental Islet TransplantCompletedNCT02821026Phase 1/2
- Incidence of Non Adherence to Treatment With Once-daily Formulation of TacrolimusStatus unknownNCT02805842Phase 3
- Ocular Penetration of Topical Tacrolimus Eye DropsStatus unknownNCT02794610Not applicable
- Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen PlanusCompletedNCT02744378Phase 2
- Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy AdultsCompletedNCT02743247Phase 1
- Allogeneic Stem Cell Transplantation for Children With CMLCompletedNCT02707393Phase 2/3
- Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant RecipientsCompletedNCT02706678Phase 4
- Use of Cyclosporin A for the Treatment of Recurrent MiscarriageStatus unknownNCT02706470Phase 2/3
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Cyclosporine Plus Methotrexate or AlemtuzumabTerminatedNCT02701517Phase 2
- Comparative Effectiveness Trial in the Treatment of Pediatric Plaque MorpheaWithdrawnNCT02680717Phase 1
- Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
- Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling DonorCompletedNCT02660684Phase 4
- Comparison Study of Psoriasis Severity Assessment ToolsCompletedNCT02655705Phase 4
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
- Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus NephritisCompletedNCT02630628Phase 3
- Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic ReceptorsCompletedNCT02608606Not applicable
- To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)CompletedNCT02601703Phase 3
- Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMDWithdrawnNCT02563782Phase 2
- Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell LymphomaWithdrawnNCT02548468Phase 1
- Once-a-day Tacrolimus Conversion Study: The OneTAC TrialStatus unknownNCT02545972Phase 4
- Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal TransplantationCompletedNCT02540395Not applicable
- Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisWithdrawnNCT02528877Phase 1
- Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant PatientsCompletedNCT02500212Phase 4
- Traumatic Brain Injury and Effects of Acute Cyclosporine AWithdrawnNCT02496975Phase 1/2
- The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant RecipientsStatus unknownNCT02496494Phase 4
- Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITACCompletedNCT02466997Phase 3
- Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic SyndromeCompletedNCT02462252Phase 2
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisCompletedNCT02457221Phase 3
- Topical Tacrolimus in Vernal KeratoconjunctivitisStatus unknownNCT02456025Phase 4
- Allogeneic Stem Cell Transplantation for Patients With Multiple MyelomaWithdrawnNCT02447055Early Phase 1
- Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen PlanusCompletedNCT02443311Phase 4
- Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant PatientsCompletedNCT02432833Phase 4
- A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in IndiaCompletedNCT02432053Phase 4
- Ciclosporin to Protect Renal Function In Cardiac SurgeryCompletedNCT02397213Phase 2
- Ciclosporin to Reduce Reperfusion Injury in Primary PCICompletedNCT02390674Phase 2
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02376049Phase 1
- Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's SyndromeStatus unknownNCT02370550Phase 4
- The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal PocketsCompletedNCT02366585Phase 2
- Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male VolunteeersCompletedNCT02341274Phase 1
- Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant PatientsStatus unknownNCT02337036Not applicable
- Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI DonorsStatus unknownNCT02314312Phase 3
- Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic PolymorphismStatus unknownNCT02311010Phase 4
- Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy SubjectsCompletedNCT02281370Phase 1
- A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus CapsuleTerminatedNCT02268201Phase 4
- Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal TransplantStatus unknownNCT02251691Phase 4
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye DiseaseCompletedNCT02229955Phase 3
- Photophoresis Versus Ciclosporine in Severe Atopic DermatitisCompletedNCT02226068Not applicable
- Cyclosporine A in Patients With Small Diameter Abdominal Aortic AneurysmsStatus unknownNCT02225756Phase 2
- Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve GastrectomyCompletedNCT02221583Phase 4
- A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic AnemiaCompletedNCT02203396Phase 2
- Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal CancerCompletedNCT02188264Phase 1
- Intra-Osseous Co-Transplant of UCB and hMSCCompletedNCT02181478Early Phase 1
- Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic NeuropathyStatus unknownNCT02176733Phase 2
- A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous NephropathyStatus unknownNCT02173106Phase 2
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney TransplantationCompletedNCT02161237Phase 4
- Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)Status unknownNCT02154854Phase 4
- Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCTCompletedNCT02144025Phase 2
- PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy SubjectsCompletedNCT02130414Phase 1
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT02122081Phase 1
- Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy ProcedureCompletedNCT02114073Phase 2
- A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisCompletedNCT02103725Phase 1
- MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney TransplantationStatus unknownNCT02091973Not applicable
- Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant PatientsCompletedNCT02077556Phase 4
- Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver TransplantationStatus unknownNCT02064777Phase 4
- Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level MonitoringWithdrawnNCT02058875Phase 4
- A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant RecipientsCompletedNCT02034747Phase 4
- Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic DermatitisCompletedNCT02004860Phase 3
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseCompletedNCT02004067Phase 4
- Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic AnemiaStatus unknownNCT01995331Phase 4
- Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&SirolimusCompletedNCT01958190Phase 4
- Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous NephropathyCompletedNCT01955187Phase 3
- Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant RecipientsStatus unknownNCT01927588Phase 4
- Pharmacokinetic Studies of Tacrolimus in Transplant PatientsCompletedNCT01889758Phase 4
- A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant SubjectsCompletedNCT01882322Phase 4
- Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
- Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus ControlTerminatedNCT01841008Phase 2/3
- A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAFCompletedNCT01839929Phase 4